| Revision as of 10:37, 31 October 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'CAS_number').← Previous edit |
Latest revision as of 00:09, 15 June 2023 edit undoEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers172,984 edits Adding local short description: "Monoclonal antibody", overriding Wikidata description "chemical compound"Tag: Shortdesc helper |
| (12 intermediate revisions by 11 users not shown) |
| Line 1: |
Line 1: |
|
⚫ |
{{Short description|Monoclonal antibody}} |
|
{{Drugbox |
|
{{Drugbox |
|
| Verifiedfields = changed |
|
| Verifiedfields = changed |
|
| verifiedrevid = 444149125 |
|
| verifiedrevid = 458274979 |
|
| image = |
|
| image = |
|
|
<!-- Monoclonal antibody data --> |
|
|
|
| ⚫ |
<!--Monoclonal antibody data--> |
|
|
| type = mab |
|
| type = mab |
|
| mab_type = mab |
|
| mab_type = mab |
|
| source = xi/i |
|
| source = xi/i |
|
| target = ] |
|
| target = ] |
|
⚫ |
<!-- Clinical data --> |
|
|
|
| ⚫ |
<!--Clinical data--> |
|
|
| tradename = |
|
| tradename = |
|
| pregnancy_AU = |
|
| pregnancy_AU = |
| Line 21: |
Line 20: |
|
| legal_status = |
|
| legal_status = |
|
| routes_of_administration = |
|
| routes_of_administration = |
|
⚫ |
<!-- Pharmacokinetic data --> |
|
|
|
| ⚫ |
<!--Pharmacokinetic data--> |
|
|
| bioavailability = |
|
| bioavailability = |
|
| protein_bound = |
|
| protein_bound = |
| Line 28: |
Line 26: |
|
| elimination_half-life = |
|
| elimination_half-life = |
|
| excretion = |
|
| excretion = |
|
⚫ |
<!-- Identifiers --> |
|
|
|
|
⚫ |
| CAS_number_Ref = {{cascite|changed|??}} |
| ⚫ |
<!--Identifiers--> |
|
|
⚫ |
| CAS_number = 357613-77-5 |
| ⚫ |
| CAS_number_Ref = {{cascite|correct|??}} |
|
| ⚫ |
| CAS_number = <!-- blanked - oldvalue: 357613-77-5 --> |
|
|
| ATC_prefix = none |
|
| ATC_prefix = none |
|
| ATC_suffix = |
|
| ATC_suffix = |
| Line 41: |
Line 38: |
|
| KEGG = D04295 |
|
| KEGG = D04295 |
|
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|
| ChemSpiderID = NA |
|
| ChemSpiderID = none |
|
⚫ |
<!-- Chemical data --> |
|
|
|
| ⚫ |
<!--Chemical data--> |
|
|
| chemical_formula = |
|
| chemical_formula = |
|
| molecular_weight = |
|
| molecular_weight = |
|
}} |
|
}} |
|
'''Galiximab''' is a ] designed for the treatment of ]. {{As of|September 2009}}, it is undergoing Phase III ]s.<ref> |
|
'''Galiximab''' is a ] designed for the treatment of ].<ref>{{cite book | vauthors = Ebadi M, Sadeghi MA, Reddy NM, Rezaei N | chapter = Immunopathology and Immunotherapy of Non-Hodgkin Lymphoma | chapter-url = https://books.google.com/books?id=v5AOEAAAQBAJ&dq=Galiximab&pg=PA178 | page = 178 | veditors = Rezaei M|title=Cancer immunology: cancer immunotherapy for organ-specific tumors |date=2020 |location=Cham | publisher = Springer Nature |isbn=978-3-03-057949-4 |edition=Second}}</ref> {{As of|September 2009}}, it is undergoing Phase III ]s.<ref>{{Cite web |url=http://www.biogenidec.com/site/pipeline.html |title=Biogen Idec: Pipeline |access-date=2009-09-24 |archive-url=https://web.archive.org/web/20080517130617/http://www.biogenidec.com/site/pipeline.html |archive-date=2008-05-17 |url-status=dead }}</ref> The drug is a ] antibody from '']'' and '']''.<ref></ref> |
|
|
|
|
|
==References== |
|
==References== |
| Line 53: |
Line 49: |
|
|
|
|
|
==External links== |
|
==External links== |
|
* |
|
* |
|
|
|
|
|
{{immunosuppressants}} |
|
{{immunosuppressants}} |
|
{{Monoclonals for immune system}} |
|
{{Monoclonals for immune system}} |
|
|
|
|
|
] |
|
|
|
|
|
|
|
|
|
{{monoclonal-antibody-stub}} |
|
{{monoclonal-antibody-stub}} |
|
{{antineoplastic-drug-stub}} |
|
{{antineoplastic-drug-stub}} |
|
|
|
|
] |
|